HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

NIVF

NewGenIvf Group Limited (NASDAQ)

Healthcare — Medical Care Facilities

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

None 1 analysts
$0.55
+$0.01 (+2.80%)
Target: $14.12 (2462.6%)
Sign in to add NIVF to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$5.55M
P/E Ratio (TTM)0.02
Forward P/E0.06
EPS (TTM)$36.48
Dividend Yield-
Profit Margin209.03%
Revenue Growth11.90%
ROE79.40%
Debt/Equity18.74
Recommendation None
Analyst Target$14.12
Analysts1
Indexes NASDAQ

Technical Indicators

RSI (14)51.2
Beta-0.08
SMA 20-
SMA 40-
52-Week High$295.20
52-Week Low$0.47
50-Day Avg$1.04
200-Day Avg$22.94
Avg Volume$5.95M
Volume770.4K

Performance Analysis

BULLISH

NIVF shows predominantly bullish signals based on its fundamentals and technicals.

+ Trading near its 52-week low ($0.47), which could present a value opportunity.
~ RSI at 51.2 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ P/E of 0.0 suggests the stock may be undervalued.
~ Modest revenue growth of 11.9% year-over-year.
+ Healthy profit margin of 209.0%.
~ Wall Street consensus is "none" from 1 analysts.
+ Average analyst target of $14.12 implies 2462.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:22 UTC

Back to Screener Export Report